{"nct_id":"NCT01479465","title":"Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma","status":"TERMINATED","status_verified_date":"2019-03","start_date":"2011-12","start_date_type":"ACTUAL","primary_completion_date":"2014-10","primary_completion_date_type":"ACTUAL","completion_date":"2015-02","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GILD"]}